SG Americas Securities’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $963K | Buy |
+22,065
| New | +$963K | ﹤0.01% | 1083 |
|
|
2025
Q1 | – | Sell |
-8,025
| Closed | -$323K | – | 3114 |
|
|
2024
Q4 | $323K | Sell |
8,025
-6,694
| -45% | -$269K | ﹤0.01% | 1514 |
|
|
2024
Q3 | $697K | Buy |
14,719
+3,832
| +35% | +$181K | ﹤0.01% | 1223 |
|
|
2024
Q2 | $325K | Buy |
10,887
+6,934
| +175% | +$207K | ﹤0.01% | 1732 |
|
|
2024
Q1 | $159K | Sell |
3,953
-14,610
| -79% | -$588K | ﹤0.01% | 1916 |
|
|
2023
Q4 | $473K | Buy |
+18,563
| New | +$473K | ﹤0.01% | 1362 |
|
|
2023
Q2 | – | Sell |
-8,772
| Closed | -$260K | – | 2403 |
|
|
2023
Q1 | $260K | Buy |
+8,772
| New | +$260K | ﹤0.01% | 2027 |
|
|
2022
Q4 | – | Sell |
-8,629
| Closed | -$188K | – | 2848 |
|
|
2022
Q3 | $188K | Sell |
8,629
-28,716
| -77% | -$626K | ﹤0.01% | 2117 |
|
|
2022
Q2 | $735K | Buy |
37,345
+30,301
| +430% | +$596K | 0.01% | 1442 |
|
|
2022
Q1 | $298K | Sell |
7,044
-3,532
| -33% | -$149K | ﹤0.01% | 1964 |
|
|
2021
Q4 | $671K | Sell |
10,576
-6,327
| -37% | -$401K | ﹤0.01% | 1760 |
|
|
2021
Q3 | $993K | Buy |
16,903
+13,381
| +380% | +$786K | ﹤0.01% | 1756 |
|
|
2021
Q2 | $171K | Sell |
3,522
-488
| -12% | -$23.7K | ﹤0.01% | 2179 |
|
|
2021
Q1 | $156K | Buy |
+4,010
| New | +$156K | ﹤0.01% | 2583 |
|